INM Return on Tangible Equity | INMED PHARMACEUTICALS INC.

INMED PHARMACEUTICALS INC. (INM) Return on Tangible Equity

2026-03-31: Return Tang Equity -252.50%.
2025-12-31: Return Tang Equity -128.06%.
2025-09-30: Return Tang Equity -102.79%.
2025-06-30: Return Tang Equity -82.67%.

Complete source-backed return tang equity history.

Available history: 2020-06-30 to 2026-03-31
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-03-31	-252.50%
2025-12-31	-128.06%
2025-09-30	-102.79%
2025-06-30	-82.67%
2025-03-31	-249.04%
2024-12-31	-327.43%
2024-09-30	-147.22%
2024-06-30	-140.02%
2024-03-31	-84.19%
2023-12-31	-71.48%
2023-09-30	51.64%
2023-06-30	-97.87%
2023-03-31	-184.77%
2022-12-31	-164.87%
2022-09-30	-276.69%
2022-06-30	-376.02%
2022-03-31	-214.94%
2021-12-31	-139.73%
2021-09-30	-81.61%
2021-06-30	-161.57%
2021-03-31	-91.77%
2020-12-31	-115.46%
2020-09-30	-227.08%
2020-06-30	-186.56%

Annual Return Tang Equity

Date	Return Tang Equity
2025-06-30	-69.09%
2024-06-30	-103.40%
2023-06-30	-78.35%
2022-06-30	-266.87%
2021-06-30	-161.57%
2020-06-30	-186.56%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Apimeds Pharmaceuticals US, Inc. (APUS)	United States	$0.008B
Ensysce Biosciences, Inc. (ENSC)	United States	$0.008B	-0.37
CNS Pharmaceuticals, Inc. (CNSP)	United States	$0.007B
EXICURE, INC. (XCUR)	United States	$0.008B	-1.54
Acurx Pharmaceuticals, Inc. (ACXP)	United States	$0.007B	-0.97
SOLIGENIX, INC. (SNGX)	United States	$0.008B
Imunon, Inc. (IMNN)	United States	$0.008B	-0.56
SYNLOGIC, INC. (SYBX)	United States	$0.007B
Bolt Biotherapeutics, Inc. (BOLT)	United States	$0.007B	-0.26
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63